111, Inc. (YI) Key Metrics

NASDAQ: YIValuation, returns, debt and efficiency ratios over 10 years.

YI key metrics, 2016–2025

Fiscal year ended December 31, 2025 · Chinese yuan

YI returns How much profit the business earns on the capital it uses.

Return on assets+1.5 pts
−0.7%
2025 · hover or tap a bar for each year
2016: −38.5%2017: −29.2% (+9.4 pts)2018: −32.9% (−3.8 pts)2019: −31.7% (+1.3 pts)2020: −19.7% (+12.0 pts)2021: −21.7% (−2.0 pts)2022: −12.6% (+9.1 pts)2023: −12.0% (+0.6 pts)2024: −2.2% (+9.8 pts)2025: −0.7% (+1.5 pts)
20162025
Free cash flow margin−0.8 pts
0.9%
2025 · hover or tap a bar for each year
2016: −45.3%2017: −22.0% (+23.3 pts)2018: −20.0% (+2.0 pts)2019: −13.5% (+6.5 pts)2020: −1.7% (+11.8 pts)2021: −5.7% (−3.9 pts)2022: −0.4% (+5.3 pts)2023: −3.1% (−2.7 pts)2024: 1.7% (+4.8 pts)2025: 0.9% (−0.8 pts)
20162025
Asset turnover−0.1%
4.90
2025 · hover or tap a bar for each year
2016: 0.932017: 1.13 (+21.3%)2018: 1.55 (+37.4%)2019: 2.50 (+61.9%)2020: 3.54 (+41.3%)2021: 4.03 (+13.8%)2022: 4.08 (+1.4%)2023: 4.56 (+11.5%)2024: 4.90 (+7.6%)2025: 4.90 (−0.1%)
20162025

YI returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

YI debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

YI cash returned to shareholders

DividendsBuybacksFree cash flow

YI key metrics in Chinese yuan

2016–2025
111, Inc. key metrics by fiscal year
2025202420232022202120202019201820172016
Returns & profitability
Return on equity (ROE)—————−80.5%−50.0%−49.3%−55.6%−63.0%
Return on invested capital (ROIC)——————−158.7%———
Return on assets (ROA)−0.7%−2.2%−12.0%−12.6%−21.7%−19.7%−31.7%−32.9%−29.2%−38.5%
Return on tangible assets−0.8%−2.3%−12.7%−12.0%−21.3%−15.1%−31.2%−24.7%−32.8%−38.7%
Free cash flow margin0.9%1.7%−3.1%−0.4%−5.7%−1.7%−13.5%−20.0%−22.0%−45.3%
Financial health
Total debtCN¥217.7MCN¥256.8MCN¥443.2MCN¥344.2MCN¥491.0MCN¥329.4MCN¥208.8MCN¥2.5MCN¥43.4MCN¥50.7M
Cash & short-term investmentsCN¥611.7MCN¥462.3MCN¥653.7MCN¥879.5MCN¥843.9MCN¥1.49BCN¥613.7MCN¥1.11BCN¥461.2MCN¥640.3M
Net debt−CN¥394.0M−CN¥205.5M−CN¥210.4M−CN¥535.3M−CN¥352.9M−CN¥1.16B−CN¥405.0M−CN¥1.10B−CN¥417.8M−CN¥589.6M
Debt / equity—————0.920.270.000.140.09
Debt / assets0.100.090.140.100.160.110.130.000.060.05
Net debt / EBITDA−217.45−8.35————————
Current ratio1.091.131.071.191.321.761.994.793.635.23
Quick ratio0.580.540.550.640.791.291.334.122.924.45
Interest coverage-0.30.1-17.4-27.6-117.0-53.7-136.3——-485.1
Working capitalCN¥171.3MCN¥307.1MCN¥188.3MCN¥510.7MCN¥671.8MCN¥1.24BCN¥735.8MCN¥1.19BCN¥529.3MCN¥728.7M
Invested capital−CN¥1.10B−CN¥848.2M−CN¥793.9M−CN¥949.9M−CN¥526.3M−CN¥803.0MCN¥371.7MCN¥119.7M−CN¥99.0M−CN¥14.1M
Tangible asset valueCN¥213.7MCN¥379.3MCN¥273.8MCN¥645.0MCN¥843.8MCN¥1.32BCN¥765.9MCN¥1.22BCN¥314.1MCN¥570.2M
Net current asset valueCN¥139.1MCN¥242.7MCN¥120.4MCN¥410.2MCN¥504.6MCN¥1.18BCN¥645.1MCN¥1.18BCN¥285.9MCN¥534.7M
Capital allocation
Dividends paid————CN¥359.9MCN¥264.6MCN¥148.9MCN¥0CN¥0CN¥0
Share buybacks (net)——CN¥0CN¥0CN¥5.9MCN¥12.0MCN¥23.0MCN¥0CN¥0CN¥0
Capex / revenue0.0%0.1%0.1%0.2%0.5%0.3%0.6%0.8%0.7%0.8%
Capex / operating cash flow3.7%5.8%————————
Capex / depreciation0.380.900.450.772.301.822.111.320.460.57
Stock-based compensation / revenue0.1%0.1%1.5%1.2%1.2%0.9%1.4%2.9%1.0%0.4%
R&D / revenue0.5%—0.8%1.0%1.5%1.1%1.6%4.0%5.0%7.1%
SG&A / revenue5.4%2.7%4.5%4.9%5.8%6.4%11.7%20.1%25.4%35.9%
Efficiency
Days sales outstanding14.216.215.214.89.95.95.412.736.440.1
Days of inventory on hand37.837.737.837.729.229.233.638.558.661.8
Days payables outstanding47.644.543.444.837.435.331.636.947.544.9
Cash conversion cycle (days)4.49.49.67.71.6-0.37.414.247.557.0
Receivables turnover25.7322.5323.9624.6737.0462.0367.3228.8010.029.10
Payables turnover7.668.208.418.159.7510.3311.539.887.688.13
Inventory turnover9.659.679.669.6812.5112.5110.869.486.235.91
Asset turnover4.904.904.564.084.033.542.501.551.130.93
Average receivablesCN¥474.6MCN¥639.1MCN¥624.0MCN¥547.8MCN¥335.4MCN¥132.3MCN¥58.7MCN¥62.0MCN¥95.8MCN¥96.1M
Average payablesCN¥1.50BCN¥1.66BCN¥1.68BCN¥1.56BCN¥1.21BCN¥758.8MCN¥328.3MCN¥170.2MCN¥113.1MCN¥98.0M
Average inventoryCN¥1.19BCN¥1.40BCN¥1.46BCN¥1.31BCN¥943.8MCN¥626.4MCN¥348.6MCN¥177.4MCN¥139.4MCN¥134.7M
Intangibles / total assets0.0%0.1%0.1%0.1%0.2%0.2%0.5%0.3%0.6%0.6%

Computed from YI's annual financial statements (latest annual report filed April 30, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in Chinese yuan; data from EODHD. Averages use the opening and closing balance of each year.

YI valuation and financial ratios

It ended the year with CN¥217.7 million of debt and CN¥611.7 million in cash and short-term investments, a net cash position of CN¥394.0 million.

See the YI income statement, the YI chart for price history, or the YI stock overview for the latest quote and news.

YI key metrics FAQ

How much debt does 111 have?

111 had total debt of CN¥217.7 million at the end of fiscal 2025 and more cash than debt.

What is 111's current ratio?

111's current ratio was 1.09 at the end of fiscal 2025: current assets were 1.09 times current liabilities.

Medical Distribution key metrics